| Literature DB >> 27008685 |
Emma Wallace1, Maike J M Uijen2, Barbara Clyne1, Atieh Zarabzadeh1, Claire Keogh1, Rose Galvin3, Susan M Smith1, Tom Fahey1.
Abstract
OBJECTIVES: Following appropriate validation, clinical prediction rules (CPRs) should undergo impact analysis to evaluate their effect on patient care. The aim of this systematic review is to narratively review and critically appraise CPR impact analysis studies relevant to primary care.Entities:
Keywords: clinical prediction rule; impact analysis; risk prediction
Mesh:
Year: 2016 PMID: 27008685 PMCID: PMC4800123 DOI: 10.1136/bmjopen-2015-009957
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Framework for the impact analysis and implementation of clinical prediction rules (CPRs).7
Figure 2Flow diagram of search strategy.
Summary of impact analysis studies of CPRs relevant to primary care
| Author, year, country | CPR name, CPR predictive accuracy (95% CI), study design | Population and study setting | Intervention and comparison | Primary outcome(s) | Results: primary outcome (95% CI) |
|---|---|---|---|---|---|
| Auleley, 1997, France | Ottawa ankle rule | 4980, ≥18 years, emergency departments of 5 Paris university teaching hospitals | Relative reduction intervention site: 22.4% (95% CI 19.8% to 24.9%), control group increase of 0.5% (95% CI 0% to 1.4%). | ||
| Cameron, 1999, Canada | Ottawa ankle | 1648, ≥18 years, male 885, female 763 | No reduction referral for ankle X-rays: intervention before 73%, after 78%, p=0.11, control: before 75%, after 65%, p=0.022 | ||
| Stiell, 1994, Canada, ER | Ottawa ankle rule | 2342, ≥18 years, emergency departments of 2 hospitals | |||
| Boutis, 2013, Canada, ER | Low-Risk Ankle Rule | 2151, children aged 3–16, emergency departments of six hospitals | Relative reduction in ankle X-rays in intervention sites compared to control sites. | ||
| Stiell, 1997, Canada, ER | Ottawa Knee Rule; | 3907, ≥18 years, emergency departments of 4 hospitals (2 community and 2 teaching) | Relative reduction of 26.4% of patients referred for knee X-ray in intervention group (77.6% vs 57.1% (p<0.001), vs relative reduction of 1.3% in control group (76.9% vs 75.9%, p=0.6) | ||
| Stiell, 2009, Canada, ER | Canadian C-spine | 11 824, ≥16 years, emergency departments of 6 hospitals | Relative reduction of 12.8% for cervical spine imaging (95% CI 9% to 16%) intervention group. Control group showed a relative increase of 12.5% (95% CI 7% to 18%) | ||
| McIsaac, 2002, Canada, Primary care | McIsaac | 621, ≥3 years, general practice, 97 participating GPs | Non-significant difference intervention vs control groups in unnecessary antibiotic prescription (20.4% vs 16.1%, p=0.29) | ||
| McIsaac, 1998, Canada, Primary care | Centor score | 396, ≥15 years, general practice, 450 participating GPs | Non-significant reduction in antibiotic prescription in intervention group (27.8%) vs control (35.7%) (p=0.09) | ||
| McGinn, 2013, USA |
Walsh rule for streptococcal pharyngitis Heckerling rule for pneumonia Walsh rule: c-statistic: 0.71 (95% CI 0.67 to 0.74) Heckerling rule: c-statistic 0.82 (0.74 to 0.9) RCT | 168 Primary care providers, 2 large academic ambulatory care centres in New York | Intervention group significantly less likely to order antibiotics than control (age-adjusted RR, 0.74; 95% CI 0.60 to 0.92). | ||
| Worrall, 2007, Canada | Modified Centor score | 533, ≥19 years, 37 practices in eastern Newfoundland | Prescription rates: CPR alone—55% RADT—27% (NS) | ||
| Little, 2013, UK | Fever PAIN | 631, ≥3 years, general practice (48 UK practices) | Greater improvements in symptom severity for CPR group compared to control (−0.33, 95% CI −0.64 to −0.02) | ||
| Pozen, 1984, USA, ER | Pozen score for chest pain | 2320, aged ≥30 male and ≥40 female, emergency departments of 6 US hospitals | 30% relative reduction in patients admitted to CCU who did not have acute coronary syndrome | ||
| Kline, 2009, USA, ER | Kline chest pain CPR | 369 adults presenting with chest pain, one emergency room in an academic urban US hospital | No significant decrease for patients admitted with no CVD diagnosis: 11% vs 5% (95% CI −0.2% to 11%), p=0.059 | ||
| Persell, 2012, primary care | Framingham risk estimate and global cardiovascular risk score | N=14 physicians, n=218 adult patients randomised to intervention, n=15 physicians, n=217 adults patients randomised to control, US primary care | No difference in the primary outcome (11% vs 11.1% OR 0.99, 95% CI 0.56 to 1.74, p=0.96) but intervention patients were more likely to receive a prescription for a statin (11.9% vs 6%, OR 2.13, 95% CI 1.05 to 4.32, p=0.038) | ||
| Grover 2007 and 2008, primary care | Framingham risk score | N=3053 adults mean age 56.4, male 66.9%, n=230 primary care physicians, 10 provinces in Canada primary care | Reduction in LDL-cholesterol level Reduction in BP |
Statistically significant reduction in LDL and total cholesterol-HDL ratio in intervention vs control and patients were more likely to reach lipid targets Patients in intervention group were more likely to receive appropriate antihypertensive treatment and more likely to start or modify treatment | |
| Hall, 2003, UK | New Zealand cardiovascular risk score | 323, aged 35–75 years, patients with no history of cardiovascular or renal disease, one UK hospital outpatient department (OPD) clinic | Prescription of risk-modifying drugs Management of CVD risk factors |
No significant between-group differences: change in diabetes treatment 42% (95% CI 34% to 50%) vs 58 (95% CI 29% to 45%), change in antihypertensive drugs 26 (95% CI 10% to 22%) vs 10% (95% CI 5% to 16%), change in lipid lowering drugs: 12% (7% to 17%) vs 9% (95% CI 4% to 14%) Referral to dietician 10% (95% CI 6% to 15%) vs 13% (95% CI 7% to 19%) | |
| Hanon, 2000, France | Framingham risk score | 1243, aged 18–75 years with hypertension attending a general physician | No difference in BP (patients with BP <140/90 mm Hg intervention: 64%, control 62%) or % patients on dual therapy (41% intervention vs 46% control) | ||
| Stiell, 2010, Canada, ER | CT head rule | 4531, alert and stable adults with minor head injury aged ≥16 years, 12 emergency departments in three provinces of Canada (6 teaching sites, 6 community sites) | Increased proportion of patients referred for CT imaging intervention: before: 62.8%, after: 76.2% (difference: 13.3% (95% CI 9.7% to 17.0%) |
CPR, clinical prediction rule; NA, non-applicable; NR, not reported; NS, non-significant.
Table of estimated effect sizes for impact analysis studies
| Author, year CPR name | Study design (n) | Sample size calculation reported (n) | Primary outcome | Effect size: crude OR of improvement in primary outcome in intervention vs control (95% CI) | Absolute risk reductions (95% CI) |
|---|---|---|---|---|---|
| Auleley, 1997 | Cluster RCT (4980) | Yes (900) | Crude OR 0.03 (0.01 to 0.06) | 22.8% (20.0% to 25.7%) | |
| Stiell, 1994 | Controlled before–after (2342) | NA | 33.4% (28.9% to 37.9%) | ||
| Cameron, 1999 | Controlled before–after (1648) | NA | Crude OR 0.96 (0.60 to 1.55) | 0.8% (−8.5% to 9.8%) | |
| Boutis, 2013 | ITS (2151) | NA | NA | NA | |
| Stiell, 1997 | Controlled before–after (3907) | NA | Crude OR 0.42 (0.35 to 0.51) | 18.8% (14.7% to 22.9%) | |
| Stiell, 2009 | Cluster RCT (11 824) | Yes (9600) | Crude OR 0.82 (0.74 to 0.90) | 5% (2.5% to 7.5%) | |
| Pozen, 1984 | ITS (2320) | NA | NA | NA | |
| Kline, 2009 | RCT (369) | Yes (400) | Crude OR 0.47 (0.22 to 1.04) | 5.4% (−0.2% to 10.9%) | |
| Persell, 2012 | Cluster RCT (425) | Yes (406) | Crude OR 0.99 (0.55 to 1.81) | 0.1% (−0.0% to 0.0%) | |
| Grover, 2007 and 2008 | RCT (3053) | Yes (3000) |
reduction in LDL-cholesterol level | NA | |
| Hall, 2003 | Pilot RCT (323) | NA | −6.0% (−16.6% to 4.7%) | ||
| Hanon, 2000 | RCT (1243) | No | −2.1% (−7.4% to 3.3%) | ||
| McIsaac, 2002 | RCT (621 patients, 97 physicians) | Yes (850 patients, 85 physicians) | Crude OR 0.71 (0.47 to 1.08) | 4.9% (−1.1% to 10.9%) | |
| McIsaac, 1998 | RCT (396) | Yes (800) | Crude OR 0.69 (0.45 to 1.05) | 8.1% (−1.0% to 17.3%) | |
| McGinn, 2013 | RCT (168) | No | Crude OR 0.66 (0.50 to 0.86) | 9.3% (3.2% to 15.3%) | |
| Worrall, 2007 | RCT (533) | Yes (196) | Crude OR 0.89 (0.57 to 1.40) | 2.9% (−8.2% to 13.9%) | |
| Little, 2013 | RCT (6131) | Yes (909) | Adjusted mean difference−0.33 (−0.64 to −0.02; p=0.04) | NA | |
| Stiell, 2010 | Cluster RCT (4531) | Yes (4800) | Crude OR 0.81 (0.69 to 0.96) | 4.7% (1.0% to 8.4%) |
CPR, clinical prediction rule.
Figure 3(A): Methodological quality assessment of impact analysis studies with RCT study design. (B) Methodological quality assessment of impact analysis studies with controlled before-after study design.